You are here:
02 September 2014
South Sudan overcomes great obstacles to protect children
Despite conflict, the South Sudanese government brings in five-in-one pentavalent vaccine with Gavi support.
30 July 2014
5-in-1 vaccine now in all 73 poorest countries
Introductions target successfully achieved – work still to be done on increasing coverage.
73 countries, five diseases, one amazing vaccine
How the 5-in-1 pentavalent vaccine is now protecting children in all of the world's poorest countries
06 May 2014
GAVI Alliance welcomes availability of Indian pentavalent vaccine
The GAVI Alliance welcomes the announcement that an additional pentavalent vaccine has received prequalification by the World Health Organization (WHO).
30 October 2013
GAVI Alliance partners reaching more children than ever before with accelerated access to vital vaccines
Mid-Term Review meeting highlights immunisation successes and challenges.
A-Z of GAVI successes and challenges - Seth Berkley’s mid-term review
Dr Seth Berkley, GAVI CEO started the Mid-Term Review with an all-encompassing presentation highlighting the Alliance’s progress in delivering against its 2011-15 strategic goals. Read the A-Z of the key themes in the presentation.
14 October 2013
GAVI Alliance on track to immunise a quarter of a billion children by 2015 and prevent nearly 4 million deaths
The GAVI Alliance is on track to meet its ambitious targets of supporting developing countries to immunise an additional quarter of a billion children by 2015, and preventing nearly four million deaths in the process. [Arabic] | [Chinese] | [German] | [Italian] | [Japanese] | [Korean] | [Spanish]
08 August 2013
GAVI responds to Medecins Sans Frontieres
In response to a press release issued by Medecins Sans Frontieres (MSF) on 8 August 2013, the GAVI Alliance issued the following statement
18 April 2013
Indian manufacturer cuts price of childhood vaccine by 30 percent
The cost of immunising millions of the world’s most vulnerable children against five deadly and debilitating diseases is set to fall, thanks to a major price reduction of one third for pentavalent vaccine. This new, more cost-effective price provides the opportunity for the GAVI Alliance to pay up to US$ 150 million less over the next four years compared with using lowest cost alternative suppliers.
03 December 2012
100 millionth person receives lifesaving meningitis vaccine
A revolutionary meningitis vaccine will reach the 100 millionth person this week in a region of Africa that has been plagued by deadly epidemics for more than a century. The milestone will take place in northern Nigeria, part of Africa’s “meningitis belt’, where the country is conducting its second seasonal immunisation campaign against the disease.
© Gavi 2014
modal window here